Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ginsenoside F2 has antiproliferative activity against breast cancer stem cells (CSCs). It induces apoptosis in breast CSCs by activating the intrinsic apoptotic pathway and mitochondrial dysfunction.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
20 mg | In stock | $ 130.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 100.00 |
Description | Ginsenoside F2 has antiproliferative activity against breast cancer stem cells (CSCs). It induces apoptosis in breast CSCs by activating the intrinsic apoptotic pathway and mitochondrial dysfunction. |
Source |
Molecular Weight | 785.01 |
Formula | C42H72O13 |
CAS No. | 62025-49-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 127.4 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ginsenoside F2 62025-49-4 Apoptosis Autophagy Metabolism Endogenous Metabolite Inhibitor Ginsenoside F-2 inhibit Ginsenoside F 2 inhibitor